Could an antiviral pill ease long COVID?
NCT ID NCT06161688
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the antiviral drug ensitrelvir can help people with Long COVID by clearing leftover virus from the body. About 40 adults with persistent symptoms will receive either the drug or a placebo. The main goal is to see if the drug improves physical health and reduces symptoms like fatigue and pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSF/Zuckerberg San Francisco General Hospital
San Francisco, California, 94110, United States